2 completed, 1 active not recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Active not recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow benphothiamine: new trials by email Literature Review of benphothiamine trials Research Report on benphothiamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam) Low Dose Benfotiamine, High Dose Benfotiamine, Placebo - Alzheimer Disease | Phase 2 | Active not recruiting | Weill Medical College of Cornell University | 406 | 2024-03-28 | 2026-09-17 |
| Benfotiamine in Alzheimer's Disease: A Pilot Study Benfotiamine - Alzheimer's Disease | Phase 2 | Completed | Burke Medical Research Institute | 71 | 2015-02-15 | 2022-06-28 |
| Effects of Vitamin B1 in Type 1 Diabetic Patients Placebo, Benfotiamine - Diabetes Mellitus, Type 1 | Phase 1 / Phase 2 | Completed | University Hospital, Aker | 67 | 2005-08-01 | 2013-05-10 |
Alzheimer Disease (2) · Cognitive Dysfunction (1) · Diabetes Complications (1) · Diabetes Mellitus, Type 1 (1)
Burke Medical Research Institute (1) · University Hospital, Aker (1) · Weill Medical College of Cornell University (1)
United States (2) · Norway (1)
Gary E Gibson, Ph.D. (1) · Gary E. Gibson, PhD (1) · Howard Feldman, MDCM (1) · Jose A. Luchsinger, MD MPH (1) · Kristian F Hanssen, MD, PhD (1) · Pasquale Fonzetti, MD, PhD (1)
PMID 22446172, PMID 33074237, PMID 38809849
R01AG043679 (1), R01AG076634 (1)